Aldebaran Therapeutics
PrivateLast Round
Accelerator
Feb 9, 2022
Total Funding Raised
$800,000
Company Overview
Aldebaran Therapeutics operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was an Accelerator round in February 2022.
Aldebaran Therapeutics is a biotechnology company that leverages human genetics and antisense oligonucleotide technology to develop precision ocular medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aldebaran Therapeutics Comparables
Compare Aldebaran Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Broadwing Bio | 78% | |
| Isarna Therapeutics | 76% | |
| City Therapeutics | 70% |
For institutional investors. Book with your work email.
Aldebaran Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Aldebaran Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 82VS | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 21, 2024
Monthly visitors increased 2110% to 221.
- Oct 30, 2024
Monthly visitors grew 151% MoM, from 53 to 133.
For institutional investors. Book with your work email.
Aldebaran Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aldebaran Therapeutics's valuation, stock price, and market status.
Is Aldebaran Therapeutics a public or private company?
Aldebaran Therapeutics is a private company.
What is the current stock price of Aldebaran Therapeutics?
Aldebaran Therapeutics is a private company, so its shares have no public market price. Caplight tracks Aldebaran Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aldebaran Therapeutics worth (valuation)?
Valuation information for Aldebaran Therapeutics is not publicly available.
Can I buy Aldebaran Therapeutics stock?
Aldebaran Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aldebaran Therapeutics's last funding round?
Aldebaran Therapeutics's most recent funding round was Accelerator on February 9, 2022.
Who are the main investors in Aldebaran Therapeutics?
Key investors in Aldebaran Therapeutics include 82VS.
Will Aldebaran Therapeutics IPO soon?
No public IPO plans have been announced for Aldebaran Therapeutics.
How can I track Aldebaran Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Aldebaran Therapeutics's shares on secondary markets.